TCG Crossover Management »

Pharvaris N V shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $35M 1.0M 34.58

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Pharvaris N V

FMR
General Atlantic
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Wellington Management Company
Polar Capital Holdings
Point72 Asset Management
Commodore Capital
Novo A/S
Saturn V Capital Management
TCG Crossover Management

View all funds holding Pharvaris N V